Gland Pharma Limited — quarter and year ended March 31, 2026 (as per the provided quarterly results document dated May 15, 2026)
This document contains audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, along with annexures (balance sheet and cash flow statements).
| Particulars | Quarter ended 31-Mar-26 Unaudited |
Quarter ended 31-Dec-25 Unaudited |
Quarter ended 31-Mar-25 Unaudited |
Year ended 31-Mar-26 Audited |
Year ended 31-Mar-25 Audited |
|---|---|---|---|---|---|
| 1. Income | |||||
| Revenue from operations | 17,427.90 | 16,953.63 | 14,249.09 | 64,306.50 | 56,165.04 |
| Other income | 1,114.66 | 631.73 | 440.29 | 3,163.28 | 2,136.08 |
| Total income | 18,542.56 | 17,585.36 | 14,689.38 | 67,469.78 | 58,301.12 |
| 2. Expenses | |||||
| Cost of materials consumed | 5,940.70 | 5,298.89 | 5,875.66 | 22,397.49 | 19,724.79 |
| Purchase of stock-in-trade | 22.78 | 15.01 | 30.99 | 66.04 | 144.88 |
| Changes in inventories of finished goods, stock-in-trade and work-in-progress | (50.17) | 452.61 | (1,027.13) | (34.23) | 1,034.14 |
| Power and fuel | 530.18 | 540.12 | 526.02 | 2,028.52 | 1,991.54 |
| Employee benefits expense | 4,115.74 | 4,241.97 | 3,733.67 | 16,288.39 | 14,015.61 |
| Depreciation and amortisation expense | 1,086.60 | 1,076.45 | 957.61 | 4,236.67 | 3,778.74 |
| Finance costs | 100.30 | 39.30 | 74.50 | 332.79 | 420.00 |
| Other expenses | 1,738.47 | 2,056.27 | 1,634.73 | 7,264.85 | 6,564.84 |
| Total expenses | 13,484.60 | 13,720.62 | 11,806.05 | 52,580.52 | 47,674.54 |
| 3. Profit before exceptional item and tax (1-2) | 5,057.96 | 3,864.74 | 2,883.33 | 14,889.26 | 10,626.58 |
| 4. Exceptional item (refer note 3) | – | 243.46 | – | 243.46 | – |
| 5. Profit before tax (3-4) | 5,057.96 | 3,621.28 | 2,883.33 | 14,645.80 | 10,626.58 |
| 6. Tax expense | |||||
| Current tax | 1,439.60 | 1,089.73 | 1,039.09 | 4,578.14 | 3,709.80 |
| Deferred tax | (48.50) | (84.00) | (19.45) | (215.95) | (78.41) |
| Taxes of earlier years | 0.11 | 0.80 | (1.72) | 10.45 | 9.93 |
| Total tax expense | 1,391.21 | 1,006.53 | 1,017.92 | 4,372.64 | 3,641.32 |
| 7. Profit for the quarter/year (5-6) | 3,666.75 | 2,614.75 | 1,865.41 | 10,273.16 | 6,985.26 |
| Attributable to: | |||||
| – Owners of the Company | 3,666.75 | 2,614.75 | 1,865.41 | 10,273.16 | 6,985.26 |
| – Non-controlling interests | – | – | – | – | – |
| 8. Other comprehensive income | |||||
| Items that will not be reclassified subsequently to profit or loss: | |||||
| Remeasurement of defined benefit plans | (66.25) | (63.92) | 8.35 | (135.62) | 15.80 |
| Deferred tax impact on remeasurement of defined benefit plans | 31.47 | 0.69 | (1.76) | 34.45 | (3.83) |
| Items that will be reclassified subsequently to profit or loss: | |||||
| Exchange differences on translation of foreign operations | (974.36) | (344.34) | (651.85) | (4,208.70) | (565.84) |
| Total other comprehensive (income)/loss, net of tax | (1,009.14) | (407.57) | (645.26) | (4,309.87) | (553.87) |
| 9. Total comprehensive income (7-8) | 4,675.89 | 3,022.32 | 2,510.67 | 14,583.03 | 7,539.13 |
| Attributable to: | |||||
| – Owners of the Company | 4,675.89 | 3,022.32 | 2,510.67 | 14,583.03 | 7,539.13 |
| – Non-controlling interests | – | – | – | – | – |
| 10. Paid up equity share capital (Face value of ₹1/- each) | 164.76 | 164.76 | 164.76 | 164.76 | 164.76 |
| 11. Other equity | – | – | – | 103,414.74 | 91,342.65 |
| 12. Earnings per equity share (Face value of ₹1/- each): | |||||
| (Not annualised for the quarter) | |||||
| Basic (₹) | 22.26 | 15.87 | 11.32 | 62.35 | 42.40 |
| Diluted (₹) | 22.23 | 15.87 | 11.32 | 62.28 | 42.40 |
| Particulars | As at 31-Mar-26 Audited | As at 31-Mar-25 Audited |
|---|---|---|
| ASSETS | ||
| Non-current assets | ||
| Property, plant and equipment | 40,519.69 | 37,505.36 |
| Right-of-use assets | 378.73 | 427.97 |
| Capital work-in-progress | 3,421.79 | 1,505.60 |
| Goodwill | 2,938.70 | 2,482.00 |
| Intangible assets | 1,086.16 | 1,057.02 |
| Deferred tax assets, net | 623.25 | 520.68 |
| Tax assets, net | 96.92 | 274.62 |
| Other non-current assets | 775.39 | 646.57 |
| Total Non-current assets | 49,840.63 | 44,419.82 |
| Current assets | ||
| Inventories | 17,438.89 | 16,852.18 |
| Financial assets | ||
| – Trade receivables | 18,913.82 | 15,165.33 |
| – Cash and cash equivalents | 33,591.06 | 25,562.09 |
| – Other financial assets | 737.41 | 4,936.20 |
| Other current assets | 4,586.67 | 5,313.58 |
| Total Current assets | 75,267.85 | 67,829.38 |
| Total Assets | 125,108.48 | 112,249.20 |
| EQUITY AND LIABILITIES | ||
| Equity | ||
| Equity share capital | 164.76 | 164.76 |
| Other equity | 103,414.74 | 91,342.65 |
| Equity attributable to the owners of the Company | 103,579.50 | 91,507.41 |
| Non-controlling interests | – | – |
| Liabilities | ||
| Non-current liabilities | ||
| Financial liabilities | ||
| – Borrowings | 699.25 | 776.64 |
| – Lease liabilities | 233.02 | 294.87 |
| Provisions | 1,956.40 | 1,459.91 |
| Deferred tax liabilities, net | 2,143.82 | 2,148.07 |
| Other non-current liabilities | 412.46 | 413.85 |
| Total Non-current liabilities | 5,444.95 | 5,093.34 |
| Current liabilities | ||
| Financial liabilities | ||
| – Borrowings | 1,734.35 | 1,915.50 |
| – Lease liabilities | 169.28 | 150.32 |
| – Trade payables | 8,338.74 | 8,204.10 |
| – Other financial liabilities | 1,486.90 | 1,110.33 |
| Provisions | 541.35 | 508.75 |
| Current tax liabilities, net | 628.60 | 736.88 |
| Other current liabilities | 3,184.81 | 3,022.57 |
| Total Current liabilities | 16,084.03 | 15,648.45 |
| Total Equity and Liabilities | 125,108.48 | 112,249.20 |
| Particulars | 31-Mar-26 Audited | 31-Mar-25 Audited |
|---|---|---|
| Cash flow from operating activities | ||
| Profit before tax | 14,645.80 | 10,626.58 |
| Adjustments for: | ||
| Depreciation and amortisation expense | 4,236.67 | 3,778.74 |
| Exceptional item (refer note 3) | 243.46 | – |
| Allowance for credit losses | 4.22 | 7.71 |
| Other assets written off | – | 18.24 |
| Bad debts written off | 1.23 | 38.52 |
| Finance costs | 332.79 | 420.00 |
| Employee stock option compensation | 454.68 | – |
| Customer claim liability reversal | – | (89.20) |
| Unrealised foreign exchange (gain)/loss, net | (418.42) | 0.10 |
| Provision no longer required written back | (2.40) | – |
| Gain on sale of investments | (33.06) | (12.27) |
| Loss on disposal of property, plant and equipment, net | 3.84 | 0.32 |
| Interest income | (2,055.46) | (2,042.78) |
| Changes in operating assets and liabilities: | ||
| Trade receivables | (2,786.18) | 422.88 |
| Inventories | 187.23 | (199.18) |
| Other assets | 836.31 | (1,642.88) |
| Trade payables and other financial liabilities | (548.83) | 269.03 |
| Provisions and other liabilities | (233.48) | 1,089.52 |
| Cash generated from operations | 14,868.40 | 12,685.33 |
| Income taxes paid, net | (4,554.53) | (3,538.03) |
| Net cash generated from operating activities (A) | 10,313.87 | 9,147.30 |
| Cash flows from investing activities | ||
| Purchase of property, plant and equipment | (4,907.63) | (3,845.42) |
| Proceeds from disposal of property, plant and equipment | 5.89 | 3.38 |
| Purchase of other intangible assets | (36.66) | (96.24) |
| Purchase of investments | (7,439.63) | (4,979.75) |
| Proceeds from sale of investments | 7,472.69 | 4,992.02 |
| Deposits with banks and others, net | 3,960.00 | 19,408.44 |
| Interest received | 2,322.62 | 1,564.93 |
| Net cash generated from investing activities (B) | 1,377.28 | 17,047.36 |
| Cash flows from financing activities | ||
| Proceeds from the exercise of employee stock option | – | 24.88 |
| Proceeds from borrowings | 225.23 | 52.83 |
| Repayment of borrowings | (937.57) | (628.24) |
| Payment towards principal portion of lease liabilities | (168.28) | (183.40) |
| Finance costs paid (including interest on lease liabilities) | (323.58) | (305.95) |
| Dividend paid | (2,965.51) | (3,294.88) |
| Net cash used in financing activities (C) | (4,169.71) | (4,334.76) |
| Net increase in cash and cash equivalents (A+B+C) | 7,521.44 | 21,859.90 |
| Effect of exchange differences on cash and cash equivalents held in foreign currency | 507.53 | 131.31 |
| Cash and cash equivalents at the beginning of the year | 25,562.09 | 3,570.88 |
| Cash and cash equivalents at the end of the year | 33,591.06 | 25,562.09 |
| Particulars | Quarter ended | Year ended |
|---|---|---|
| 31-Mar-26 (Unaudited) | 31-Dec-25 (Unaudited) | |
| 1. Income | ||
| Revenue from operations | 12,615.92 | 11,775.13 |
| Other income | 1,063 |